Advertisement

Uncategorized

The following article is written by Manisha Shah-Bugaj, director of marketing in the surgical energy division of Gyrus ACMI, an Olympus company. Approximately 600,000 hysterectomies (surgical removal of the uterus) are performed annually in the United States, with an estimated…

Advertisement

The FDA has approved a risk evaluation and mitigation strategy for Cephalon's Fentora and Actiq drugs to manage breakthrough pain in opioid-tolerant patients with cancer, according to a Cephalon news release.

Advertisement